{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:26:13Z","timestamp":1792121173515,"version":"4.4.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The molecular mechanisms of the development and progression of bladder cancer are poorly understood. The objective of this study was to analyze the expression of Bmi-1 protein and its clinical significance in human bladder cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We examined the expression of Bmi-1 mRNA and Bmi-1 protein by RT-PCR and Western blot, respectively in 14 paired bladder cancers and the adjacent normal tissues. The expression of Bmi-1 protein in 137 specimens of bladder cancer and 30 specimens of adjacent normal bladder tissue was determined by immunohistochemistry. Statistical analyses were applied to test the relationship between expression of Bmi-1, and clinicopathologic features and prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Expression of Bmi-1 mRNA and protein was higher in bladder cancers than in the adjacent normal tissues in 14 paired samples (<jats:italic>P<\/jats:italic> &lt; 0.01). By immunohistochemical examination, five of 30 adjacent normal bladder specimens (16.7%) versus 75 of 137 bladder cancers (54.3%) showed Bmi-1 protein expression (<jats:italic>P<\/jats:italic> &lt; 0.05). Bmi-1 protein expression was intense in 20.6%, 54.3%, and 78.8% of tumors of histopathological stages G1, G2, and G3, respectively (<jats:italic>P<\/jats:italic> &lt; 0.05). Expression of Bmi-1 protein was greater in invasive bladder cancers than in superficial bladder cancers (81.5% versus 32.5%, <jats:italic>P<\/jats:italic> &lt; 0.05). In invasive bladder cancers, the expression of Bmi-1 protein in progression-free cancers was similar to that of cancers that have progressed (80.0% versus 82.4%, <jats:italic>P<\/jats:italic> &gt; 0.5). In superficial bladder cancers, the expression of Bmi-1 protein in recurrent cases was higher than in recurrence-free cases (62.5% versus 13.7%, <jats:italic>P<\/jats:italic> &lt; 0.05). Bmi-1 expression was positively correlated with tumor classification and TNM stage (<jats:italic>P<\/jats:italic> &lt; 0.05), but not with tumor number (<jats:italic>P<\/jats:italic> &gt; 0.05). Five-year survival in the group with higher Bmi-1 expression was 50.8%, while it was 78.5% in the group with lower Bmi-1 expression (<jats:italic>P<\/jats:italic> &lt; 0.05). Patients with higher Bmi-1 expression had shorter survival time, whereas patients with lower Bmi-1 expression had longer survival time (<jats:italic>P<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Expression of Bmi-1 was greater in bladder cancers than in the adjacent normal tissues. The examination of Bmi-1 protein expression is potentially valuable in prognostic evaluation of bladder cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-9-61","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T19:16:13Z","timestamp":1235070973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Expression of Bmi-1 is a prognostic marker in bladder cancer"],"prefix":"10.1186","volume":"9","author":[{"given":"Zi-Ke","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-An","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Bing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Sheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"1395_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","volume":"51","author":"RT Greenlee","year":"2001","unstructured":"Greenlee RT, Hi-Harmon MB, Murray T, Thun M: Cancer Statistics, 2001. CA Cancer J Clin. 2001, 51: 15-36. 10.3322\/canjclin.51.1.15.","journal-title":"CA Cancer J Clin"},{"key":"1395_CR2","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1200\/JCO.2003.09.028","volume":"21","author":"M Laufer","year":"2003","unstructured":"Laufer M, Ramalingam S, Schoenberg MP, Haisfield-Wolf ME, Zuhowski EG, Trueheart IN, Eisenberger MA, Nativ O, Egorin MJ: Intravesical Gemcitabine therapy for superficial transitional cell carcinoma of the bladder phase I and pharmacokinetic study. J Clin Oncol. 2003, 21: 697-703. 10.1200\/JCO.2003.09.028.","journal-title":"J Clin Oncol"},{"key":"1395_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0022-5347(01)62747-2","volume":"160","author":"JP Stein","year":"1998","unstructured":"Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, Figueroa AJ, Skinner DG, Cote RJ: Prognostic markers in bladder cancer: a contemporary review of the literature. J Urol. 1998, 160: 645-659. 10.1016\/S0022-5347(01)62747-2.","journal-title":"J Urol"},{"key":"1395_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00001703-200310000-00008","volume":"15","author":"S Eissa","year":"2003","unstructured":"Eissa S, Kassim S, EI-Almady O: Detection of bladder tumours role of cytology, morphology-based assays, biochemical and molecular markers. Cuur Opin Obstet Gynecol. 2003, 15: 395-403. 10.1097\/00001703-200310000-00008.","journal-title":"Cuur Opin Obstet Gynecol"},{"key":"1395_CR5","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/S0022-5347(01)63924-7","volume":"159","author":"T Shinka","year":"1998","unstructured":"Shinka T, Ogura H, Morita T, Nishikawa T, Fujinaga T, Ohkawa T: Relationship between glutathione S-transferase M1 deficiency and urothelial cancer in dye workers exposed to aromatic amine. J Urol. 1998, 159: 380-383. 10.1016\/S0022-5347(01)63924-7.","journal-title":"J Urol"},{"key":"1395_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOU.0b013e3282f1c5c1","volume":"18","author":"SF Shariat","year":"2008","unstructured":"Shariat SF, Karam JA, Lerner SP: Molecular markers in bladder cancer. Curr Opin Urol. 2008, 18: 1-8. 10.1097\/MOU.0b013e3282f9b3e5.","journal-title":"Curr Opin Urol"},{"key":"1395_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/0092-8674(91)90383-A","volume":"65","author":"Y Haupt","year":"1991","unstructured":"Haupt Y, Alexander WS, Barri G, Klinken SP, Adans JM: Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Emu-myc transgenic mice. Cell. 1991, 65: 753-763. 10.1016\/0092-8674(91)90383-A.","journal-title":"Cell"},{"key":"1395_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/0092-8674(91)90382-9","volume":"65","author":"M van Lohuizen","year":"1991","unstructured":"van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Bems A: Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell. 1991, 65: 737-752. 10.1016\/0092-8674(91)90382-9.","journal-title":"Cell"},{"key":"1395_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1101\/gad.8.7.757","volume":"8","author":"NM van der Lugt","year":"1994","unstructured":"Lugt van der NM, Domen J, Linder sK, van Roon M, Robanus-Maandag E, te Riele H, Valk van der M, Deschamps J, Sofroniew M, van Lohuizen M: Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 1994, 8: 757-769. 10.1101\/gad.8.7.757.","journal-title":"Genes Dev"},{"key":"1395_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0092-8674(00)81162-9","volume":"93","author":"V Pirrotta","year":"1998","unstructured":"Pirrotta V: Polycombing the genome: PcG, trxG, and chromatin silencing. Cell. 1998, 93: 333-336. 10.1016\/S0092-8674(00)81162-9.","journal-title":"Cell"},{"key":"1395_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature01572","volume":"423","author":"J Lessard","year":"2003","unstructured":"Lessard J, Sauvageau G: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 2003, 423: 255-60. 10.1038\/nature01572.","journal-title":"Nature"},{"key":"1395_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1359\/JBMR.041006","volume":"20","author":"M Saito","year":"2005","unstructured":"Saito M, Handa K, Kiyono T, Hattori S, Yokoi T, Tsubakimoto T, Harada H, Noguchi T, Toyoda M, Sato S, Teranaka T: Immortalization of cementoblast progenitor cells with Bmi-1 and TERT. J Bone Miner Res. 2005, 20: 50-57. 10.1359\/JBMR.041006.","journal-title":"J Bone Miner Res"},{"key":"1395_CR13","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1128\/MCB.25.12.5183-5195.2005","volume":"25","author":"T Mori","year":"2005","unstructured":"Mori T, Kiyono T, Imabayashi H, Takeda Y, Tsuchiya K, Miyoshi S, Makino H, Matsumoto K, Saito H, Ogawa S, Sakamoto M, Hata J, Umezawa A: Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol. 2005, 25: 5183-5195. 10.1128\/MCB.25.12.5183-5195.2005.","journal-title":"Mol Cell Biol"},{"key":"1395_CR14","first-page":"2409","volume":"61","author":"S Be\u00e0","year":"2001","unstructured":"Be\u00e0 S, Tort F, Pinyol M, Puig X, Hern\u00e1ndez L, Hern\u00e1ndez S, Fernandez PL, van Lohuizen M, Colomer D, Campo E: BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001, 61: 2409-2412.","journal-title":"Cancer Res"},{"key":"1395_CR15","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1054\/bjoc.2001.1791","volume":"84","author":"S Vonlanthen","year":"2001","unstructured":"Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, Borner MM, van Lohuizen M, Betticher DC: The bmi-1 oncoprotein is differentially expressed in nonsmall cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer. 2001, 84: 1372-1376. 10.1054\/bjoc.2001.1791.","journal-title":"Br J Cancer"},{"key":"1395_CR16","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1182\/blood.V97.12.3896","volume":"97","author":"FJ van Kemenade","year":"2001","unstructured":"van Kemenade FJ, Raaphorst FM, Blokzijl T, Fieret E, Hamer KM, Satijn DP, Otte AP, Meijer CJ: Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood. 2001, 97: 3896-3910. 10.1182\/blood.V97.12.3896.","journal-title":"Blood"},{"key":"1395_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.breast.2004.02.010","volume":"13","author":"JH Kim","year":"2004","unstructured":"Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH, Lee Y, Choe IS, Kim JW: Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast. 2004, 13: 383-388. 10.1016\/j.breast.2004.02.010.","journal-title":"Breast"},{"key":"1395_CR18","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.2353\/ajpath.2007.060754","volume":"170","author":"H Cui","year":"2007","unstructured":"Cui H, Hu B, Li T, Ma J, Alam G, Gunning WT, Ding HF: Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am J Pathol. 2007, 170: 1370-1378. 10.2353\/ajpath.2007.060754.","journal-title":"Am J Pathol"},{"key":"1395_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1182\/blood-2005-06-2393","volume":"107","author":"K Mihara","year":"2006","unstructured":"Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H, Yasunaga S, Takihara Y, Kimura A: Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and prognosis of the patients. Blood. 2006, 107: 305-308. 10.1182\/blood-2005-06-2393.","journal-title":"Blood"},{"key":"1395_CR20","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-06-0094","volume":"66","author":"LB Song","year":"2006","unstructured":"Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX: Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006, 66: 6225-6232. 10.1158\/0008-5472.CAN-06-0094.","journal-title":"Cancer Res"},{"key":"1395_CR21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.lungcan.2004.11.026","volume":"48","author":"RH Breuer","year":"2005","unstructured":"Breuer RH, Snijders PJ, Sutedja GT, Sewalt RG, Otte AP, Postmus PE, Meijer CJ, Raaphorst FM, Smit EF: Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions. Lung Cancer. 2005, 48: 299-306. 10.1016\/j.lungcan.2004.11.026.","journal-title":"Lung Cancer"},{"key":"1395_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"AJCC Cancer Staging Manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Balch CM, Fleming ID, Fritz A, Haller DG, Morrom M, David L: AJCC Cancer Staging Manual. 2002, New York: AJCC Springer-Verlag, 335-340. 6","edition":"6"},{"key":"1395_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/bcr1760","volume":"9","author":"J Silva","year":"2007","unstructured":"Silva J, Garc\u00eda V, Garc\u00eda JM, Pe\u00f1a C, Dom\u00ednguez G, D\u00edaz R, Lorenzo Y, Hurtado A, S\u00e1nchez A, Bonilla F: Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients. Breast Cancer Res. 2007, 9: 55-10.1186\/bcr1760.","journal-title":"Breast Cancer Res"},{"key":"1395_CR24","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.leu.2404623","volume":"21","author":"M Chowdhury","year":"2007","unstructured":"Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, Kimura A: Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia. 2007, 21: 1116-1122.","journal-title":"Leukemia"},{"key":"1395_CR25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-5347(17)35014-0","volume":"151","author":"AA Sandberg","year":"1994","unstructured":"Sandberg AA, Berger CS: Review of chromosome studies in urological tumors. Cytogenetics andmolecular genetics of bladder cancer. J Urol. 1994, 151: 545-560.","journal-title":"J Urol"},{"key":"1395_CR26","first-page":"57","volume":"75","author":"MA Knowles","year":"1995","unstructured":"Knowles MA: Molecular genetics of bladder cancer. Br J Urol. 1995, 75: 57-66.","journal-title":"Br J Urol"},{"key":"1395_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S0092-8674(03)00157-0","volume":"112","author":"V Orlando","year":"2003","unstructured":"Orlando V: Polycomb, epigenomes, and control of cell identity. Cell. 2003, 112: 599-606. 10.1016\/S0092-8674(03)00157-0.","journal-title":"Cell"},{"key":"1395_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/16476","volume":"397","author":"JJ Jacobs","year":"1999","unstructured":"Jacobs JJ, Kieboom K, Marino S, Depinho RA, van Lohuizen M: The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 1999, 397: 164-168. 10.1038\/16476.","journal-title":"Nature"},{"key":"1395_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.bjc.6603529","volume":"96","author":"MK Kang","year":"2007","unstructured":"Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, Christensen R, Han T, Park NH: Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007, 96: 126-133. 10.1038\/sj.bjc.6603529.","journal-title":"Br J Cancer"},{"key":"1395_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI200420800","volume":"113","author":"IK Park","year":"2004","unstructured":"Park IK, Morrison SJ, Clarke MF: Bmi-1, Stem cells, and senescence regulation. J Clin Invest. 2004, 113: 175-179.","journal-title":"J Clin Invest"},{"issue":"16","key":"1395_CR31","first-page":"4736","volume":"62","author":"GP Dimri","year":"2002","unstructured":"Dimri GP, Martinez JL, Jacobs JJ, Keblusek P, Itahana K, van Lohuizen M, Campisi J, Wazer DE, Band V: The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 2002, 62 (16): 4736-4745.","journal-title":"Cancer Res"},{"key":"1395_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1474-9728.2004.00137.x","volume":"4","author":"AJ Ball","year":"2005","unstructured":"Ball AJ, Levine F: Telomere-independent cellular senescence in human fetal cardiomyocytes. Aging Cell. 2005, 4: 21-30. 10.1111\/j.1474-9728.2004.00137.x.","journal-title":"Aging Cell"},{"key":"1395_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1600-0560.2006.00587.x","volume":"34","author":"CM Reinisch","year":"2007","unstructured":"Reinisch CM, Uthman A, Erovic BM, Pammer J: Expression of BMI-1 in normal skin and inflammatory and neoplastic skin lesions. J Cutan Pathol. 2007, 34: 174-180. 10.1111\/j.1600-0560.2006.00587.x.","journal-title":"J Cutan Pathol"},{"key":"1395_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/01.ju.0000067626.37837.3e","volume":"170","author":"LL Chang","year":"2003","unstructured":"Chang LL, Yeh WT, Yang SY, Wu WJ, Huang CH: Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J Urol. 2003, 170: 595-600. 10.1097\/01.ju.0000067626.37837.3e.","journal-title":"J Urol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-9-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-9-61\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-9-61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-9-61.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:23:08Z","timestamp":1630462988000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-9-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["1395"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-9-61","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"1 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"61"}}